Wikipedia -WSS

Wikipedia

author：comprehensive 2025-09-28 21:11:33 - browse：26971

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

LONDON — Starting in the new year, a team of researchers in the U.K. and Denmark will begin recruiting patients for a study driven by a pressing question in medicine: How should new obesity medications be incorporated into regular practice?

Trials have demonstrated that the powerful drugs can help people shed weight in dramatic ways, but clinicians are still trying to sort out how to best use them. The medicines, after all, are pricey, come with side effects, and won’t work for everyone. And despite the excitement around these drugs, known as GLP-1s, some people might prefer or see better results with the other approaches that have long been the foundation of obesity treatment, from diet to surgery.

“These drugs clearly are very effective, and that is fantastic,” said Susan Jebb, a professor of diet and population health at the University of Oxford and one of the leaders of the project. “But we have other options for treating obesity. What we need to do now in research is understand which treatments, for which patients, at which stage of their disease.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Erich Jarvis studies song birds to learn about human stuttering

hotspot

WSS

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Congress must reauthorize a committee to support older Americans

Bring on the sabbaticals for nurses

Pfizer, Moderna say biotech, pharma drug development is a sprint

Readout Newsletter: Illumina, CRISPR, Regeneron

Readout LOUD podcast, live from the STAT Breakthrough Summit East

explore

Wikipedia

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Texas board proposes rules on abortion law emergency exemption

Sports medicine is finally prioritizing gender equality

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

After affirmative action ruling, medical educators look to 'holistic review'

Pfizer, Moderna say biotech, pharma drug development is a sprint

How to save PrEP access — and even expand it

Anthos stroke drug appears safer than common blood thinner

Medicare details structure of new drug price negotiation program

Childhood cancer progress stalls for Black, Hispanic kids: Report

hotspot

Mirador, a new biotech startup, launches with $400 million

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Surge of respiratory disease in China has likely explanation

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Ransomware attacks on hospitals: Study outlines patient impact

CRISPR pioneers react to Casgevy, first gene

entertainment

hotspot

hotspot

entertainment